Invezz
Search documents
Here's why the Tilray stock price has crashed and what next
Invezz· 2025-11-17 18:01
Core Viewpoint - Tilray Brands stock price has experienced a significant decline, dropping over 53% from its peak this year, indicating a bearish market trend for the company [3][5]. Stock Performance - The stock price fell from a high of $2.32 in October to the current price of $1.08, marking the lowest level since September 11 [3][4]. - The stock has moved below critical technical levels, including the 61.8% Fibonacci Retracement level at $1.11 and the 50-day and 100-day Exponential Moving Averages [4][5]. Market Conditions - The ongoing decline is attributed to the uncertainty surrounding the reclassification of cannabis by Donald Trump, which could impact the cannabis industry significantly [6][7]. - The delay in decision-making regarding cannabis reclassification has contributed to the overall downturn in cannabis stocks [7]. Financial Performance - Tilray's recent earnings report showed a modest revenue increase of 5% to $209 million, with net income rising to $1.5 million [7]. - Cannabis revenue also rose by 5% to $64.4 million, while the beverage segment, a key investment area, saw a decline in revenue to $55.7 million, raising concerns about its strategic direction [7][8]. Balance Sheet - On a positive note, Tilray's cash balance has improved, reaching $264 million, indicating some financial stability despite the stock price decline [8].
Alphabet stock jumps 6% to hit record high: what's going on?
Invezz· 2025-11-17 17:36
Alphabet Inc. shares jumped nearly 6% on Monday, hitting a record high, after Berkshire Hathaway Inc. disclosed a multibillion-dollar position in the Google parent — a rare endorsement from the value-... ...
Plug Power stock price is crashing as losses soar: time to buy the dip?
Invezz· 2025-11-17 17:13
Plug Power stock price has pulled back and moved into a bear market, erasing some of the gains made in September and October. PLUG has retreated by over 50% from its highest point this year, lowering ... ...
Webull stock price gets highly oversold: is it a buy ahead of earnings?
Invezz· 2025-11-17 17:01
Webull stock price has been in a strong bearish trend in the past few months, erasing all gains it made shortly after going public a few months ago. BULL was trading at $8.80 on Friday, down sharply f... ...
Why is Goldman Sachs poised for its best M&A performance in 24 years?
Invezz· 2025-11-17 16:35
Core Insights - Goldman Sachs is benefiting from a significant resurgence in mergers and acquisitions activity, marking the most robust dealmaking environment in nearly 25 years [1] Company Summary - The firm has secured a leading position in the current wave of global dealmaking, capitalizing on increased merger and acquisition activities [1] Industry Summary - The overall surge in M&A activity indicates a renaissance in the dealmaking landscape, suggesting a favorable environment for investment banks like Goldman Sachs [1]
Options data reveals where Netflix stock is headed after 10-for-1 split
Invezz· 2025-11-17 16:19
Core Insights - Netflix Inc (NASDAQ: NFLX) has recently executed a 10-for-1 stock split, which has significantly reduced its share price from over $1,000 to approximately $110 [1] Company Summary - The stock split is aimed at making shares more accessible to a broader range of investors by lowering the price per share [1]
Is the expensive Palo Alto Networks stock a buy or sell ahead of earnings?
Invezz· 2025-11-17 16:09
Core Viewpoint - Palo Alto Networks' stock price has recently declined from a year-to-date high of $223 in October to the current price of $205, indicating a notable pullback in the stock's performance [1] Group 1 - The stock price movement highlights a decrease of approximately 8.06% from the peak [1] - Palo Alto Networks is expected to be in the spotlight this week due to upcoming events or announcements that may impact its stock performance [1]
Tesla stock up 2% even as Thiel cuts stake: here's what analysts want you to do
Invezz· 2025-11-17 15:31
Tesla stock traded higher on Monday after several analysts reiterated bullish views on the electric vehicle maker, citing optimism over its Full Self-Driving (FSD) technology and progress on the compa... ...
Novo Nordisk is now offering its anti-obesity drug for as low as $199 per month
Invezz· 2025-11-17 15:19
Core Insights - Novo Nordisk has implemented significant price reductions for its leading GLP-1 medications, Wegovy and Ozempic, allowing patients to access the lowest doses for only $199 per month [1] Pricing Strategy - The new pricing strategy targets cash-paying patients, making these medications more affordable and accessible [1] Market Impact - This move is expected to enhance patient access to these popular weight management and diabetes treatment drugs, potentially increasing market share for Novo Nordisk [1]
Is Goldman Sachs GPIQ ETF a buy as YTD inflows near $2 billion?
Invezz· 2025-11-17 15:15
Core Insights - The Goldman Sachs Nasdaq-100 Premium Income ETF (GPIQ) has experienced significant demand from American investors this year, leading to a record high in its stock price [1] - Total inflows into GPIQ have surged, indicating strong investor interest and confidence in the fund [1] Performance Metrics - GPIQ's stock has reached a record high, reflecting its successful performance in the market [1] - The increase in total inflows suggests a robust growth trajectory for the ETF, highlighting its appeal among investors [1]